Howard Hauptman is a Rheumatologist in Baltimore, Maryland. Dr. Hauptman has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica. Dr. Hauptman is currently accepting new patients.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Arthritis, Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica.

Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included granulomatosis with polyangiitis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. Dr. Hellmann is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Behcet Disease, Necrotizing Vasculitis, Takayasu Arteritis, and Juvenile Temporal Arteritis.

Francesca Okoye is a Rheumatologist in Baltimore, Maryland. Dr. Okoye has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. Dr. Okoye is currently accepting new patients.

Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy.

Dr. Ana-Maria Orbai is an Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and psoriatic arthritis. Dr. Orbai earned her M.D. from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She completed internship and residency training in internal medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai completed her post-doctoral fellowship training in rheumatology at Johns Hopkins. During her fellowship she earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Orbai directs the Psoriatic Arthritis Program in the Johns Hopkins Arthritis Center. Her clinical focus is psoriatic arthritis and spodyloarthritis. Dr. Orbai's research aims to understand psoriatic disease subtypes and improve treatment strategies for people with psoriatic arthritis. Dr. Orbai was awarded a Rheumatology Research Foundation Scientist Development award in 2014 and a Jerome L Greene Foundation Scholar award in 2018. Dr. Orbai is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Arthritis, and Rheumatoid Arthritis (RA).

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE).

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Dr. Antiochos sees patients in the Division of Rheumatology on the Bayview campus and conducts basic science research into the pathogenesis of rheumatic diseases in the Division's laboratory. Lab website: Brendan Antiochos MD. Dr. Antiochos is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Granulomatosis with Polyangiitis, Necrotizing Vasculitis, Sjogren Syndrome, and Vasculitis.

An associate professor of medicine, and the L. Douglas Lee and Barbara Levinson-Lee Professorship in Clinical Practice, Steven J. Kravet, M.D., M.B.A., serves as president of the largest primary care group in Maryland, Johns Hopkins Community Physicians; a network of suburban community practices that serves more than 900,000 patients annually at more than 40 locations throughout Maryland, Washington, D.C., and Northern Virginia. A third-generation pharmacist and community health care advocate who prizes the relationships that develop between patients and care-givers, Dr. Kravet has spent more than two decades at Johns Hopkins Bayview Medical Center, providing strong leadership in a wide variety of community health services. Before being named president of Johns Hopkins Community Physicians in 2009, Dr. Kravet served as medical director of inpatient medical services, internal medicine and ambulatory services, as well as chief medical officer for quality and patient safety, and deputy director for clinical activity in the Department of Medicine at Johns Hopkins Bayview Medical Center. As a member of the faculty in the Division of General Internal Medicine, he has obtained invaluable insights into the practical realities of primary care. Having earned an M.B.A. in Johns Hopkins’ Business of Medicine program, he has an excellent understanding of the business issues affecting outpatient care. The American College of Physicians has used Dr. Kravet’s research on primary care processes to formulate plans for redesigning health care practices. After receiving his pharmacist degree from the Rutgers University College of Pharmacy in 1988, Dr. Kravet ran his family’s pharmacy in Spotswood, N.J., until 1992, during which time he worked on obtaining his medical degree from the Robert Wood Johnson Medical School. He arrived at Johns Hopkins Bayview as a resident in 1992 and has spent his entire career at Johns Hopkins. Among his honors are the Resident Teaching Award and the Department of Medicine Chairman’s Award. Dr. Kravet practices all aspects of primary care medicine, including prevention and cortisone shots. Dr. Kravet is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Tinea Versicolor.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis.

Dr. Bruce Leff is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the department of health policy and management in the Johns Hopkins Bloomberg School of Public Health and the Department of Community and Public Health in the Johns Hopkins School of Nursing. Dr. Leff is an internationally recognized leader and researcher in the development, evaluation and dissemination of novel models of care for older adults, including the Hospital at Home, Guided Care, geriatric service line models and medical house call practices. In addition, his research interests extend to issues related to multi-morbidity, performance measurement and case-mix issues. He has a strong interest in health policy issues, is a past Health and Aging Policy Fellow of the American Political Science Association, and has served on multiple technical expert panels for the National Quality Forum, NCQA, and Centers for Medicare and Medicaid Services. An award-winning teacher and mentor, Dr. Leff directed the basic Medicine Clerkship in the School of Medicine until 2021. He is a past-president of the American Academy of Home Care Physicians, past-member of the Board of Regents of the American College of Physicians. He is also past- Chair of the Council of the American Board of Internal Medicine (ABIM), as well as the past-Chair of the ABIM Geriatric Medicine Board. He currently serves on the Board of Trustees of the ABIM Foundation. Dr. Leff received his B.A. from the University of Pennsylvania in 1983 and his M.D. from New York University in 1987. After residency and fellowship training at Johns Hopkins, he served as a medical officer in the US Army in Seoul, Korea, before joining the faculty in the Department of Medicine in 1994. Dr. Leff is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Dementia, Severe Acute Respiratory Syndrome (SARS), Hypertension, and COVID-19.

Karan Chawdhary is a Rheumatologist in Halethorpe, Maryland. Dr. Chawdhary is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Chondrocalcinosis 2, Systemic Sclerosis (SSc), and Tissue Biopsy.

Sam Serafi is a Rheumatologist in Baltimore, Maryland. Dr. Serafi is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Sjogren Syndrome, and Rheumatoid Arthritis (RA).

Tazeen Rehman is a Rheumatologist in Baltimore, Maryland. Dr. Rehman is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Fibromyalgia.

Janet O'mahony is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. O'mahony is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Familial Hypertension, and Hypertension.

Eric Fisher is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Complex Regional Pain Syndrome, Sitosterolemia, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Mohammad Oreizi-Esfahani is a Rheumatologist in Baltimore, Maryland. Dr. Oreizi-Esfahani is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Ankylosing Spondylitis. Dr. Oreizi-Esfahani is currently accepting new patients.

Bernadette Siaton is a Rheumatologist in Baltimore, Maryland. Dr. Siaton is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Relapsing Polychondritis, Gout, Behcet Disease, and Lupus Nephritis. Dr. Siaton is currently accepting new patients.

Violeta Rus is a Rheumatologist in Baltimore, Maryland. Dr. Rus is rated as an Experienced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Lupus Nephritis, Systemic Lupus Erythematosus (SLE), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Rus is currently accepting new patients.